Imaging lung health effects of e-cigarette use
Official title: Hyperpolarized Xenon-129 MR Imaging of the Lung:E-cigarette Sub-study
Run by University of Virginia · NCT04662658 · Data updated 2026-11-12
This study is testing how e-cigarette use affects lung health in healthy young adults by using a special imaging technique to see how well their lungs work.
Quick facts
| Phase | Phase1; Phase2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 24 (estimated) |
| Sponsor | University of Virginia Academic / other |
| Locations | 1 site (Charlottesville, Virginia) |
| Status | Recruiting |
| Started | November 5, 2020 |
| Main results expected | December 2022 |
| Study ends | December 2025 |
| Registry record updated | December 10, 2020 |
| Trial ID | NCT04662658 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are healthy young adults aged 21-30 who have been using e-cigarettes for more than six months and have no history of lung disease.
✕Probably not a fit
Patients with a history of lung disease or significant medical conditions that could affect lung function will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to investigate the health effects of e-cigarettes on the lungs of healthy young adults using a novel imaging technique called hyperpolarized xenon-129 MRI. The study will assess lung function and gas exchange by quantifying regional ventilation and gas uptake in the lungs. Participants will include e-cigarette users and non-smokers, with careful monitoring of their health status and lung function. The goal is to provide insights into the potential pulmonary risks associated with e-cigarette use, which is currently poorly understood.
Why it matters
Potential benefit: If successful, this study could provide critical data on the pulmonary effects of e-cigarettes, informing public health policies and individual health decisions.
How similar studies have gone: While there have been studies on the effects of e-cigarettes, this specific approach using hyperpolarized xenon-129 MRI is novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Male and female subjects 21-30 years of age 2. At baseline health with no recent illnesses or medical conditions that would preclude enrollment as assessed by the Principal Investigator 3. Ability to understand a written informed consent form and comply with the requirements of the study. 4. E-cigarette use for more than 6 months preceding the date of enrollment and less than a 5 pack year smoking history (e-cigarette users) OR less than a 5 pack year smoking history (non-smoker group). 5. No diagnosis of any lung disease (pre-bronchodilator FEV1/FVC normal on the day of screening defined by \> 95thCI of NHANES III, ATS/ERS guideline) Exclusion Criteria: 1. History of any lung disease 2. Control (non-smoking) group: History of illegal drug use by inhalation 3. History of CNS disease including stroke and dementia, end-stage liver disease, coronary artery disease, renal failure 4. Acute infection of any kind in the previous 6 weeks 5. Pregnancy or a possibility of pregnancy 6. Anemia 7. Inability to undergo MR imaging based on the standard clinical criteria for MRI
Where it's running
-
Snyder Building 480 Ray C. Hunt Drive
Charlottesville, Virginia, United States Recruiting
Study contacts
- Principal investigator: Yun M shim, MD — University of Virginia
- Study coordinator: Roselove Asare
- Email: rnn3b@virginia.edu
- Phone: 434-243-6074
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Carcinogen and toxicant exposure among young adults who co-use e-cigarettes and cannabis
This project will measure nicotine, cannabis, and toxicant levels in blood and urine and compare use behaviors in 18–25-year-olds who primarily use e-cigarettes, cannabis, or both.
-
Evaluating how flavor affects smokers switching to e-cigarettes
This study tests whether different e-cigarette flavors can help smokers switch from regular cigarettes to e-cigarettes more easily.
-
Cardiorespiratory and muscular fitness in children with obesity and autism
This study tests whether cardiorespiratory fitness and handgrip strength differ between children with obesity who have autism and those who do not, and how these fitness measures relate to body size, composition, and cardiometabolic health.
-
Obesity's effect on muscle insulin action and cardiorespiratory fitness in type 1 diabetes
This will see if muscle insulin resistance and excess weight are linked to lower cardio fitness in adults with type 1 diabetes compared with healthy controls before and after a high-intensity interval training program.
-
CARRII Native Intervention Optimization: Finding the Best Online Help for Native Women at Risk of Alcohol-Exposed Pregnancy
This trial tests different online components of CARRII to see which mix best reduces risk of alcohol-exposed pregnancy among Native women who could become pregnant and drink.
-
Use of a smartwatch to track hot flashes in men receiving androgen deprivation therapy
This project will try using a smartwatch to record hot flashes and other health signals in men with prostate cancer on androgen deprivation therapy and compare those records with daily survey reports.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.